Home › Funds › ATLAS CAPITAL ADVISORS INC. › ELV

ATLAS CAPITAL ADVISORS INC. position in ELV

ELEVANCE HEALTH · Health Care

ATLAS CAPITAL ADVISORS INC. reported holding 3,648 shares of ELV (ELEVANCE HEALTH) in its Q3 2026 13F filing — a position valued at US$9.6M, representing 0.92% of its reported portfolio and ranking #26 among its reported holdings. ATLAS CAPITAL ADVISORS INC. has disclosed ELV holdings in 11 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)3.65K sh
Reported value held$9.59M
Portfolio Weight0.92%
First reportedQ3 2023
Last changeAdd
Updated2026-11-09

Last updated: 2026-11-09 · Source: SEC EDGAR Form 13F-HR

How ATLAS CAPITAL ADVISORS INC.'s ELV position evolved

ATLAS CAPITAL ADVISORS INC. first disclosed a stake in ELV in Q3 2023 at 4,451 shares (US$1.9M). The position peaked in Q3 2026 at 3,648 shares, worth US$9.6M. Across 11 filings, ATLAS CAPITAL ADVISORS INC. increased the stake 3 time(s), trimmed it 5 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 3,648 shares valued at US$9.6M — an increase of 93 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 4.45K $1.94M New
Q4 2023 4.62K $2.18M Add
Q1 2024 4.59K $2.38M Reduce
Q3 2024 4.55K $2.37M Reduce
Q4 2024 3.66K $1.35M Reduce
Q1 2025 3.66K $1.59M Hold
Q2 2025 3.54K $1.38M Reduce
Q4 2025 3.50K $1.23M Reduce
Q1 2026 3.50K $1.03M Hold
Q2 2026 3.56K $1.37M Add
Q3 2026 3.65K $9.59M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ELV and 13F data

ELV (ELEVANCE HEALTH) is a Health Care company. 23 other funds we track also report a position in ELV — the largest reported positions include Wellington Management Group (US$3.56B), WELLINGTON MANAGEMENT GROUP LLP (US$3.56B), Sanders Capital, LLC (US$2.25B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ELV

All ELV fund holders →

FAQ

How long has ATLAS CAPITAL ADVISORS INC. held ELV?

ATLAS CAPITAL ADVISORS INC. has disclosed ELV holdings in 11 of the last 13 reported quarters, going back to Q3 2023.

What is ATLAS CAPITAL ADVISORS INC.'s current position in ELV?

As of Q3 2026, ATLAS CAPITAL ADVISORS INC. holds 3.65K shares of ELV (ELEVANCE HEALTH), valued at $9.59M, representing 0.92% of its reported portfolio and ranking #26.

Has ATLAS CAPITAL ADVISORS INC. been buying or selling ELV?

In the latest 13F filing (Q3 2026), ATLAS CAPITAL ADVISORS INC. increased its position in ELV. The position peaked in Q3 2026 at 3.65K shares.

Which other funds hold ELV?

Other major institutional holders of ELV include Wellington Management Group, WELLINGTON MANAGEMENT GROUP LLP, Sanders Capital, LLC, among 23 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.